Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

about

Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma.

P2860

Q35171777-96FA872A-4C5C-4F0C-BD8B-71282610CD87

P2860

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

Item

http://www.wikidata.org/entity/Q42801091

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

@en

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

@nl

type

Item

label

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

@en

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

@nl

prefLabel

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

@en

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

@nl

P1476

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

@en

P2093

Chu Zhang

http://www.w3.org/2001/XMLSchema#string

Fengying Peng

http://www.w3.org/2001/XMLSchema#string

Hui Han

http://www.w3.org/2001/XMLSchema#string

Jiao Huang

http://www.w3.org/2001/XMLSchema#string

Lizhen Ma

http://www.w3.org/2001/XMLSchema#string

Xianfeng Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Recent developments in thyroid eye disease

Graves' ophthalmopathy

Thalidomide and its derivatives: emerging from the wilderness.

Immunological consequences of thalidomide treatment in Sjögren's syndrome

Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.

TSH stimulates adipogenesis in mouse embryonic stem cells

New developments in adipogenesis.

Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.

Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy

Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.

P2888

s12020-012-9600-8

P304

248-255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12020-012-9600-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1050126750

http://www.w3.org/2001/XMLSchema#string

P698

22237514

http://www.w3.org/2001/XMLSchema#string

P921

thalidomide

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

about

P2860

P2860

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921